| Bioactivity | Tau protein aggregation-IN-1 (Compound 0c) is a Tau protein aggregation inhibitor. Tau protein aggregation-IN-1 can be used in the study of protein folding disorders such as Alzheimer's disease, dementia, Parkinson's disease, Huntington's disease and prion-based spongiform encephalopathies[1]. |
| Name | Tau protein aggregation-IN-1 |
| CAS | 916179-45-8 |
| Formula | C17H11BrN2O2 |
| Molar Mass | 355.19 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Michael D Carter, et al. Treatment of protein folding disorders. WO2006125324A1. |
Tau protein aggregation-IN-1
CAS: 916179-45-8 F: C17H11BrN2O2 W: 355.19
Tau protein aggregation-IN-1 (Compound 0c) is a Tau protein aggregation inhibitor. Tau protein aggregation-IN-1 can be u
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.